Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 4, 2024
Aripiprazole/Sertraline Combination: Clinical and Cost-Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)-Protocol for a Nested Qualitative StudyIsobel Hoppe, Stuart Watson, Caroline Kemp, et al.BMC Anesthesiology|October 11, 2014
Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, AustraliaDharshi Karalapillai, Laurence Weinberg, Jonathan Galtieri, et al.International Journal of Surgery (London, England)|September 7, 2023
Effect of differing flap reconstruction strategies in perineal closure following advanced pelvic oncological resection: a retrospective cohort studyNorman J Galbraith, Catherine McCollum, Lucia Di Mascio, et al.Journal of Affective Disorders|July 19, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trialMichael Berger, Timea Helter, Lumbini Azim, et al.The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 13, 2023
Ghana 3D Telemedicine International MDT: A proof-of-concept studySteven Lo, Anna Rose, Spencer Fowers, et al.Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.Pageof 14